Stage II Breast Cancer: CL's Survivor Story

Patient Info: CL, Female, 50s | Stage II

CL completed chemotherapy and mastectomy for Stage II breast cancer, was no longer taking medication, and continued half-year follow-up with her doctor.

Our Cancer StoriesRead more →

Stage II Invasive Lobular Carcinoma: Kristel's Survivor Story

Patient Info: Kristel, Female, Under 40 | Stage II

After double mastectomy and 25 rounds of radiation for Stage II invasive lobular carcinoma, Kristel moved into post-treatment support and created a virtual group for others with ILC.

Lobular Breast Cancer AllianceRead more →

Stage II Invasive Lobular Carcinoma: Alma's Patient Story

Patient Info: Alma, Female | Stage II

Alma had Stage II invasive lobular carcinoma treated with lumpectomy, chemotherapy, radiation, and planned 10 years of tamoxifen, then found a local recurrence 4.5 years after diagnosis.

Lobular Breast Cancer AllianceRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Tanya's Patient Story

Patient Info: Tanya, Female, 40s | Stage II

Biomarkers: Genetic testing negative; Oncotype DX score 27; MammaPrint low risk; ER-positive

Tanya had Stage II ER-positive breast cancer with a large lobular tumor found on MRI, underwent bilateral mastectomy with immediate reconstruction, completed 4 rounds of chemotherapy, and started tamoxifen.

Lobular Breast Cancer AllianceRead more →

Stage II Colorectal Adenocarcinoma: Robert's Survivor Story

Patient Info: Robert, Male | Stage II

High-risk Stage II colon adenocarcinoma treated with surgery removing the ascending colon and 10 cm of distal small bowel; latest source text supports survivorship after relatively early detection but does not explicitly state NED or no recurrence.

Fight Colorectal CancerRead more →

Stage II Colorectal Cancer: Deondre's Survivor Story

Patient Info: Deondre Williams, Male, Under 40 | Stage II

Stage II colon cancer survivor who is described as cancer-free and now works as a life coach, speaker, and colorectal cancer awareness advocate.

Colorectal Cancer AllianceRead more →

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.orgRead more →

Stage II BRCA2 Breast Cancer: Rachel's Patient Story

Patient Info: Rachel Zitofsky, Female, Under 40 | Stage II

Biomarkers: BRCA2 mutation

Rachel was doing well 4.5 years after Stage II breast cancer diagnosis and continued tamoxifen; her BRCA2 result also led her sister to expanded testing and preventive care.

Memorial Sloan KetteringRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan KetteringRead more →

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan KetteringRead more →

Stage II Invasive Ductal Carcinoma: Dwan's Survivor Story

Patient Info: Dwan Thomas, Female | Stage II

Biomarkers: HER2-negative; estrogen-positive

Dwan completed treatment for Stage II HER2-negative, estrogen-positive invasive ductal carcinoma in 2017 and later became active in MD Anderson advocacy and fundraising efforts.

MD AndersonRead more →

Stage II Ovarian Cancer: Elizabeth's Survivor Story

Patient Info: Elizabeth Jardinella, Female, Under 40 | Stage II

Cancer-free for about 2 years, with surveillance scans continuing to show no evidence of disease while she takes maintenance letrozole.

MD AndersonRead more →

Stage II Invasive Lobular Carcinoma: Jane's Patient Story

Patient Info: Jane, Female, 50s | Stage II

Nearly 3 years into her breast-cancer journey, she was continuing long-term hormone therapy and active patient advocacy.

Lobular Breast Cancer AllianceRead more →

Delayed adrenal insufficiency after lung cancer immunotherapy

Patient Info: Anonymized, male, 60s | Stage II

Imaging and bronchoscopy in November 2024 showed no lung-cancer recurrence or metastasis. By June 2026, he had not experienced another adrenal crisis while continuing hormone replacement.

PubMed CentralRead more →

Stage II Breast Cancer: Naomi's Patient Story

Patient Info: Naomi Arbel-Brodd, Female | Stage II

Twenty years after her 2006 diagnosis, she had returned to UT MD Anderson as a weekly volunteer supporting other women receiving breast cancer care.

MD AndersonRead more →

HER2-Positive Breast Cancer Treatment Followed by Multiple Myeloma

Patient Info: Anonymized, female, 50s | Stage II

Biomarkers: ER-negative; PR-negative; HER2 3+; Ki-67 70%

Postoperative imaging showed no breast cancer recurrence or distant metastasis, and the breast cancer was described as stable when a separate multiple myeloma diagnosis was made.

PubMed CentralRead more →

Breast cancer treatment changed after severe colitis

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: HER2-positive, ER-negative, PR-negative

In April 2025, follow-up evaluation showed no evidence of breast cancer recurrence.

PubMed CentralRead more →

Stage II Breast Cancer: Renée's Survivor Story

Patient Info: Renée, Female, Under 40 | Stage II

Renée described her health as stable and her treatment as working. She remained on a long-term hormone-based anti-cancer regimen and was still healing from reconstruction complications rather than describing herself as cancer-free.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: Germline BRCA1 mutation; triple-negative breast cancer

Surgical pathology was all clear on June 17 after a strong chemotherapy response. Lucy described herself as cancer-free and continued oncology reviews every 3–4 months while planning delayed reconstruction.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Melissa's Survivor Story

Patient Info: Melissa, Female | Stage II

Biomarkers: Triple-negative breast cancer; BRCA testing negative; NBN gene mutation identified on later testing

Melissa completed pregnancy-adapted cancer treatment, later underwent risk-reducing surgery and reconstruction, and was raising both daughters.

The Patient StoryRead more →

Stage II Breast Cancer: Wendi's Survivor Story

Patient Info: Wendi Kushner | Stage II

Biomarkers: Triple-positive

After the clinical trial, lumpectomy pathology showed a complete pathological response with no residual cancer in the breast or lymph nodes.

MD AndersonRead more →

Stage IIA triple-negative neuroendocrine breast carcinoma with chemoimmunotherapy response

Patient Info: Anonymized, Female, 70+ | Stage II

Biomarkers: Triple-negative neuroendocrine breast carcinoma with PD-L1 CPS >=10, and reported germline BRCA1/2 mutation.

As of March 2025, 12 months after surgery, follow-up imaging and tumor-marker testing showed no local recurrence or distant metastasis, and she remained in good general condition.

PubMed CentralRead more →

Allison’s Stage 2C Colorectal Cancer Story

Patient Info: Allison, Female, Under 40 | Stage II

As of June 2026, Allison was sharing her Stage IIC colorectal cancer experience as a patient advocate after concurrent radiation/Xeloda, major surgery with J-pouch and temporary ileostomy, and chemotherapy.

The Patient StoryRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Cat's Survivor Story

Patient Info: Cat, Female | Stage II

Biomarkers: ER-positive; Oncotype recurrence risk discussed

As of June 2026, Cat described being cancer-free after bilateral mastectomy, 4 months of chemotherapy, reconstruction, and a period on tamoxifen for ER-positive Stage IIB breast cancer.

The Patient StoryRead more →